Socio economic disparities in type 2 diabetes in african american populations: a proteomic approach to identify biological pathways - african american adults have a substantially higher risk of type 2…

Active Grant Awarded

Award ID
R21MD020457
Recipient
Awarding agency
Obligated
$216,676

Award facts

Completion date 12% complete
Place of performance
Washington, DC 20037, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services' National Institutes of Health, National Institute for Minority Health and Health Disparities, awarded George Washington University a grant of $216,676 under the Minority Health and Health Disparities Research program (CFDA 93.307) on September 9, 2026, with an ultimate completion date of May 31, 2028. The recipient will evaluate how individual and neighborhood socioeconomic position affects proteomic profiles and type 2 diabetes risk among African American participants in the Jackson Heart Study (N=1,878) and the Multi-Ethnic Study of Atherosclerosis (N=1,458), with over 10 years of follow-up. The work will identify proteomic signatures for socioeconomic position, using Jackson Heart Study data for discovery and internal testing and Multi-Ethnic Study of Atherosclerosis data for validation, and will run pathway enrichment analyses on the biological processes affected by low socioeconomic position. A second specific aim evaluates psychological factors, beginning with chronic stress. Place of performance is Washington, DC 20037.

Description

Socio economic disparities in type 2 diabetes in african american populations: a proteomic approach to identify biological pathways - african american adults have a substantially higher risk of type 2 diabetes (T2D) than non-hispanic white adults. In nationally representative nhanes data, the prevalence of diabetes was 20.4% among non-hispanic black participants, compared with 12.1% among non-hispanic white participants. Low neighborhood and individual socioeconomic position (SEP) further increase this risk. SEP may affect health through various mediators, including psychological and lifestyle factors that influence biological pathways such as chronic inflammation. However, the biological mechanisms through which low SEP affects T2D risk remain poorly understood. Recent advances in proteomics enable the high-throughput profiling of numerous plasma proteins, offering a unique opportunity to comprehensively investigate the biological mechanisms linking low SEP to the development of T2D. We will evaluate the impact of SEP on proteomic profiles and T2D risk in african american participants from the jackson heart study (JHS; N=1878) and the multi-ethnic study of atherosclerosis (mesa; N=1458) with over 10 years of follow-up. SEP will be operationalized as cumulative individual SEP (e.g., parental education, income, wealth) and neighborhood SEP based on census tract data. The JHS and mesa cohorts also include detailed data on lifestyle, psychological factors, proteomic markers (SOMASCAN), and repeated laboratory-based assessments of diabetes. Our specific aims are: 1). To examine the association between individual and neighborhood SEP and proteomic markers using cross-sectional and longitudinal analyses. We will identify proteomic signatures for SEP using JHS for discovery and internal testing and mesa for validation. We will also conduct pathway enrichment analyses to identify biological processes affected by low SEP. 2). To evaluate whether psychological (chronic stress, depression) and lifestyle (e.g., diet, physical activity, adiposity, smoking) factors mediate associations between SEP and proteomic profiles. 3). To assess prospective associations between SEP-associated proteomic profiles and T2D risk. Our findings will provide insights into the biological pathways by which low SEP affects metabolic health and identify potential targets for future interventions to reduce diabetes risk.

Quick answers

Who received award R21MD020457?

R21MD020457 was awarded to George Washington University (The) by National Institute for Minority Health and Health Disparities (National Institutes of Health) on September 9, 2026.

How much is award R21MD020457 worth?

$216,676 has been obligated on R21MD020457.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award